Shanru Zuo

489 total citations
24 papers, 359 citations indexed

About

Shanru Zuo is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Shanru Zuo has authored 24 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Nephrology and 6 papers in Epidemiology. Recurrent topics in Shanru Zuo's work include Acute Kidney Injury Research (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Epigenetics and DNA Methylation (3 papers). Shanru Zuo is often cited by papers focused on Acute Kidney Injury Research (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Epigenetics and DNA Methylation (3 papers). Shanru Zuo collaborates with scholars based in China and United States. Shanru Zuo's co-authors include Xiao‐cong Zuo, Jianglin Wang, Chunjiang Wang, Yueliang Xie, Wenjun Yin, Shikun Liu, Can Hu, Ge Zhou, Kun Liu and Zhenzhen Deng and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Shanru Zuo

24 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanru Zuo China 11 103 81 68 46 44 24 359
Chloe Y. Y. Cheung Hong Kong 14 140 1.4× 84 1.0× 16 0.2× 22 0.5× 19 0.4× 29 456
Mingxia Yuan China 11 67 0.7× 75 0.9× 24 0.4× 72 1.6× 5 0.1× 28 356
Chaoyang Chen China 13 78 0.8× 59 0.7× 22 0.3× 5 0.1× 37 0.8× 41 397
Hui Lou China 9 64 0.6× 73 0.9× 8 0.1× 16 0.3× 19 0.4× 28 297
Lingyan Chen China 10 53 0.5× 125 1.5× 16 0.2× 12 0.3× 5 0.1× 23 317
Dhekra Alnaqeb Saudi Arabia 10 83 0.8× 61 0.8× 112 1.6× 22 0.5× 19 0.4× 17 454
Noriko Takebe Japan 13 52 0.5× 103 1.3× 11 0.2× 10 0.2× 21 0.5× 23 368
Nattachet Plengvidhya Thailand 18 224 2.2× 78 1.0× 19 0.3× 31 0.7× 16 0.4× 52 677

Countries citing papers authored by Shanru Zuo

Since Specialization
Citations

This map shows the geographic impact of Shanru Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanru Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanru Zuo more than expected).

Fields of papers citing papers by Shanru Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanru Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanru Zuo. The network helps show where Shanru Zuo may publish in the future.

Co-authorship network of co-authors of Shanru Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Shanru Zuo. A scholar is included among the top collaborators of Shanru Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanru Zuo. Shanru Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Wenjun, Xiaoqing Lin, Hai‐long Piao, et al.. (2024). Hypoalbuminemia and cisplatin-induced acute kidney injury. Frontiers in Pharmacology. 15. 1510477–1510477. 2 indexed citations
2.
Du, Mingyue, et al.. (2023). Deep convolutional neural networks using an active learning strategy for cervical cancer screening and diagnosis. SHILAP Revista de lepidopterología. 3. 1101667–1101667. 6 indexed citations
3.
Cui, Yinghong, Shanru Zuo, Yucong Liu, et al.. (2023). ZBTB40 is a telomere-associated protein and protects telomeres in human ALT cells. Journal of Biological Chemistry. 299(9). 105053–105053. 2 indexed citations
4.
Zuo, Shanru, et al.. (2022). Extrachromosomal Circular DNA (eccDNA): From Chaos to Function. Frontiers in Cell and Developmental Biology. 9. 792555–792555. 40 indexed citations
5.
Fang, Weijin, et al.. (2022). Effect of miRNA-200b on the proliferation of liver cancer cells via targeting SMYD2/p53 signaling pathway.. PubMed. 47(10). 1303–1314. 2 indexed citations
6.
7.
Zuo, Shanru, Yucong Liu, Yide Yang, et al.. (2021). Nuclear Factor Related to KappaB Binding Protein ( NFRKB ) Is a Telomere-Associated Protein and Involved in Liver Cancer Development. DNA and Cell Biology. 40(10). 1298–1307. 6 indexed citations
8.
Tan, Jia Ping, Shanru Zuo, Feilong Wu, et al.. (2021). Integrated genomic analysis reveals regulatory pathways and dynamic landscapes of the tRNA transcriptome. Scientific Reports. 11(1). 5226–5226. 4 indexed citations
9.
Yin, Wenjun, Lingyun Zhou, Yueliang Xie, et al.. (2020). Protective Effects of Amlodipine Pretreatment on Contrast-Induced Acute Kidney Injury And Overall Survival In Hypertensive Patients. Frontiers in Pharmacology. 11. 44–44. 8 indexed citations
10.
Hu, Can, Ge Zhou, Kun Liu, et al.. (2020). CaMKII as a key regulator of contrast-induced nephropathy through mPTP opening in HK-2 cells. Cellular Signalling. 75. 109734–109734. 10 indexed citations
11.
Yin, Wenjun, Ge Zhou, Lingyun Zhou, et al.. (2020). Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort. BMC Nephrology. 21(1). 45–45. 5 indexed citations
12.
Zhou, Lingyun, Wenjing Cheng, Wenjun Yin, et al.. (2019). A novel rat model of contrast-induced nephropathy based on dehydration. Journal of Pharmacological Sciences. 141(1). 49–55. 13 indexed citations
13.
Song, Liying, Weijin Fang, Yang He, et al.. (2019). Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway. BMC Complementary and Alternative Medicine. 19(1). 138–138. 20 indexed citations
14.
Yin, Wenjun, Bikui Zhang, Jun Zhao, et al.. (2019). Development and validation of a more accurate estimating equation for glomerular filtration rate in a Chinese population. Kidney International. 95(3). 636–646. 63 indexed citations
15.
Zuo, Shanru, Xiao‐cong Zuo, Yang He, et al.. (2017). Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma. Journal of Cancer. 9(2). 321–330. 36 indexed citations
16.
Zhou, Lingyun, Shanru Zuo, Xiaofeng Guan, et al.. (2017). Dlitiazem inhibits the oxidative stress induced by angiotensin II through growth hormone secretagogue receptor type 1a in human umbilicus vein endothelial cells. Biomedicine & Pharmacotherapy. 89. 76–82. 2 indexed citations
17.
Li, Sun, Ping Xu, Yangang Zhou, Shanru Zuo, & Yiping Liu. (2016). Meta-analysis of polymorphism rs6311 and rs6313 in the5-HT2ARgene and schizophrenia. Nordic Journal of Psychiatry. 71(1). 1–11. 20 indexed citations
18.
Chen, Qingjie, Jing Li, Shanru Zuo, et al.. (2015). Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients. Renal Failure. 37(4). 601–606. 13 indexed citations
19.
Zuo, Shanru, et al.. (2014). A meta‐analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection. The Journal of Clinical Pharmacology. 55(3). 288–297. 27 indexed citations
20.
Wang, Jianglin, Ren Guo, Shikun Liu, et al.. (2014). Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. Chinese Medical Journal. 127(20). 3645–3650. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chloe Y. Y. Cheung Breakdown of academic impact, for papers by Mingxia Yuan Breakdown of academic impact, for papers by Chaoyang Chen Breakdown of academic impact, for papers by Hui Lou Breakdown of academic impact, for papers by Lingyan Chen Breakdown of academic impact, for papers by Dhekra Alnaqeb Breakdown of academic impact, for papers by Noriko Takebe Breakdown of academic impact, for papers by Nattachet Plengvidhya
Rankless by CCL
2026